CELEX: 62014TN0839
Language: en
Date: 2014-12-22 00:00:00
Title: Case T-839/14: Action brought on 22 December 2014 — Alnapharm v OHIM — Novartis (Alrexil)

23.2.2015   
            
            
               EN
            
            
               Official Journal of the European Union
            
            
               C 65/49
            
         Action brought on 22 December 2014 — Alnapharm v OHIM — Novartis (Alrexil)
   (Case T-839/14)
   (2015/C 065/66)
   Language in which the application was lodged: English
   
      Parties
   
   
      Applicant: Alnapharm GmbH & Co. KG (Hamburg, Germany) (represented by: H. Heldt, lawyer)
   
      Defendant: Office for Harmonisation in the Internal Market (Trade Marks and Designs) (OHIM)
   
      Other party to the proceedings before the Board of Appeal: Novartis AG (Basel, Switzerland)
   
      Details of the proceedings before OHIM
   
   
      Applicant: The other party to the proceedings before the Board of Appeal
   
      Trade mark at issue: Community word mark ‘Alrexil’ — Application for registration No 10 306 249
   
      Procedure before OHIM: Opposition proceedings
   
      Contested decision: Decision of the Fourth Board of Appeal of OHIM of 23 October 2014 in Case R 1723/2013-4
   
      Form of order sought
   
   The applicant claims that the Court should:
   
               —
            
            
               annul the contested decision and refer the case back to the Board of Appeal of OHIM;
            
         
               —
            
            
               order OHIM to pay the costs.
            
         
      Plea in law
   
   
               —
            
            
               Infringement of Article 8(1)(b) of Regulation No 207/2009.